AdaptHealth sells diabetes unit to Cardinal Health for $235 million

Corporate Action
โดย RTTNews·Read original
Summary · why it matters

AdaptHealth is divesting its Diabetes Health business to Cardinal Health in a $235 million cash deal. The unit provides continuous glucose monitors, insulin pumps, and related services for diabetes treatment. AdaptHealth says the sale will allow it to redeploy capital toward its core sleep and respiratory care segments, strengthen its balance sheet, and pursue growth opportunities. The transaction is subject to regulatory review and other closing conditions, with a financial update expected during AdaptHealth's second quarter 2026 earnings call on August 4. Deutsche Bank Securities is advising AdaptHealth, while J.P. Morgan Securities is advising Cardinal Health.

Impact on stocks 3

Aging Population▲ · 1 stocks
Adapthealth Corp
AHCO
▲ PositiveCapitalrelevance

Divests diabetes unit for $235M cash, strengthens balance sheet and refocuses on core segments.

Health Care▲ · 1 stocks
Cardinal Health Inc
CAH
▲ PositiveCapitalrelevance

Acquires diabetes unit for $235M, expanding its product portfolio in diabetes care.

Financials▲ · 1 stocks

Off-coverage companies 1

J.P. Morgan Securities LLCPrivate± Mixed
relevance

© 2026 MarketDXNews